Rani Therapeutics Holdings, Inc.RANI決算レポート
Nasdaq
RANI Q3 2025 Key Financial Metrics
売上高
$0
粗利益
N/A
営業利益
$-7.3M
純利益
$-5.4M
粗利益率
N/A
営業利益率
N/A
純利益率
N/A
前年比成長
N/A
EPS
$-0.12
Rani Therapeutics Holdings, Inc. Q3 2025 財務サマリー
Rani Therapeutics Holdings, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-5.4M (up 20.2% YoY) (N/A margin). Cost of goods sold was N/A.
主要財務指標
| 総売上高 | $0 |
|---|---|
| 純利益 | $-5.4M |
| 粗利益率 | N/A |
| 営業利益率 | N/A |
| 報告期間 | Q3 2025 |
Rani Therapeutics Holdings, Inc. 四半期売上・純利益の履歴
Rani Therapeutics Holdings, Inc. quarterly results over the last 6 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q3 2025 | $0 | — | $-5.4M | N/A |
| Q2 2025 | $0 | — | $-6.7M | N/A |
| Q1 2025 | $172.0K | — | $-7.3M | -4223.3% |
| Q3 2024 | $0 | — | $-6.8M | N/A |
| Q2 2024 | $0 | — | $-6.8M | N/A |
| Q1 2024 | $0 | — | $-7.5M | N/A |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| 売上高 | $0 | $0 | $0 | $172000 | $0 | $0 |
| 前年比成長 | N/A | N/A | N/A | N/A | N/A | N/A |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| 総資産 | $53.5M | $43.7M | $43.5M | $24.1M | $16.9M | $10.1M |
| 総負債 | $39.0M | $38.2M | $37.8M | $29.5M | $26.1M | $22.1M |
| 株主資本 | $7.4M | $2.8M | $3.1M | $-3.1M | $-5.6M | $-7.9M |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| 営業CF | $-9.4M | $-9.0M | $-8.4M | $-8.1M | $-5.8M | $-5.1M |